0
Your cart
SupportPublications with AlexotechAn astrocyte-derived cytokine TIMP-1 restores synaptic plasticity in an Alzheimer’s disease model

An astrocyte-derived cytokine TIMP-1 restores synaptic plasticity in an Alzheimer’s disease model

bioRxiv (2023): 2023-03. Sarkar, Sukanya, et al.
DOI: https://doi.org/10.1101/2023.03.18.533245


Abstract:

"The influence of astrocyte-secreted cytokines on neuronal health in Alzheimer’s disease (AD) is poorly understood, despite their increasing recognition as potential molecules for therapeutic targeting. Recently, we demonstrated that an anti-inflammatory cytokine, tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) is robustly secreted by astrocytes early in response to amyloid-β (Aβ) but is reduced in its prolonged presence. Here, we found strikingly diminished levels of TIMP-1 in the brain of six-month-old 5xFAD mice concomitant with high levels of Aβ, versus wild-type mice. Intracerebroventricular injection of TIMP-1 in 5xFAD mice ameliorated their cognitive functions. TIMP-1 not only ensured neuronal viability against apoptosis and aberrant autophagy in the AD model by binding to neuronal CD63 receptors, but also conferred synapse–specific effects. Synaptosomal analysis revealed TIMP-1 elevates dendritic spine size and protein levels, likely by promoting post-synaptic long-term potentiation in hippocampus, independent of pre-synaptic activity. TIMP-1 induced brain-derived neurotrophic factor (BDNF) and BDNF-mediated post-synaptic signaling. Therefore, we identify TIMP-1 as a multifunctional cytokine with distinct protective mechanisms-of-action on neurons and propose it as a promising therapeutic candidate in AD."

Related Product: Amyloid-Beta 1-42 Human, Synthetic

Back to top